CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo for advanced cancers halted early
Disease control TerminatedThis study tested a new drug (SOT101) combined with pembrolizumab in 166 people with advanced solid tumors like lung, colon, and ovarian cancer. The goal was to see if the combination could shrink tumors. The study was stopped early, and participants were expected to need ongoing…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
New combo therapy for tough prostate cancer shows promise in early trial
Disease control TerminatedThis study tested a combination of two drugs, denosumab and enzalutamide, in men with advanced prostate cancer that no longer responds to hormone therapy and has spread to the bones. The goal was to see if the combination could delay cancer growth longer than historical results w…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Cancer Trials Ireland • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Promising prostate cancer combo study halted before results
Disease control TerminatedThis study tested a combination of two drugs, cabozantinib and abiraterone, in men with a type of advanced prostate cancer that no longer responds to hormone therapy and has spread to the bones. The goal was to see if the combination could delay cancer growth or death. However, t…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Exelixis • Aim: Disease control
Last updated May 04, 2026 16:24 UTC